Zyprexa's restricted reimbursement is in dispute

The Ministry of Health and Welfare announced its restricted reimbursement plan on Zyprexa (olanzapine) to take effect on September 1, to this effect that that if other inexpensive drugs compared to Zyprexa are ineffective in the treatment of psychosis, Zyprexa will be still under the current insurance coverage but in the case of deviating such acceptable criteria, patients have to shoulder extr...